Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer-Reference-Cited by-同舟云学术

Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer

Published:2022-05-31 Issue:10 Volume:19 Page:3586-3599
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Olson Madeline T.¹²^ORCID,Aguilar Eric N.³,Brooks Cory L.³,Isder Carly C.²⁴,Muilenburg Kathryn M.²⁴,Talmon Geoffrey A.²⁵,Ly Quan P.²⁶,Carlson Mark A.²⁶⁷^ORCID,Hollingsworth Michael A.¹²,Mohs Aaron M.²⁴⁸^ORCID

Affiliation:

1. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

2. Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

3. Department of Chemistry and Biochemistry, California State University Fresno, Fresno, California 93740, United States

4. Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

5. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

6. Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

7. Department of Surgery, VA Medical Center, Omaha, Nebraska 68105, United States

8. Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

Funder

National Cancer Institute

University of Nebraska Medical Center

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00203

Reference58 articles.

1. Cancer Statistics, 2021

2. Treatment landscape of metastatic pancreatic cancer

3. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

4. Pancreatic cancer

5. Neoadjuvant Treatment for Pancreatic Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene;Translational Cancer Research;2024-05

2. Targeting mucins for fluorescence-guided surgery of pancreatic cancer;Molecular-Guided Surgery: Molecules, Devices, and Applications X;2024-03-13

3. Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6;Molecular Cancer Therapeutics;2024-02-23

4. Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies;Journal of Ovarian Research;2024-01-16

5. Innovative strategies to study epigenetic regulation and advance precision medicine;Comprehensive Precision Medicine;2024